Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion type Assertion NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_head.
- NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion description "[Primary screening with HC2 generally detects 23% (95% confidence interval, CI: 13-23%) more CIN-2, CIN-3, or cancer compared to cytology at cut-off atypical squamous cells of undetermined significance (ASCUS) or LSIL, but is 6% (95% CI: 4-8%) less specific.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_provenance.
- NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion evidence source_evidence_literature NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_provenance.
- NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion SIO_000772 16950021 NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_provenance.
- NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion wasDerivedFrom befree-20150227 NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_provenance.
- NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_assertion wasGeneratedBy ECO_0000203 NP987753.RA7hsb0MHANyjA4ApxbPAygEZgSEM9pG9cfwRam5CjUkQ130_provenance.